共 50 条
- [2] Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review FRONTIERS IN IMMUNOLOGY, 2022, 13
- [7] Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab European Journal of Dermatology, 2019, 29 : 213 - 215
- [8] Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid JOURNAL OF DERMATOLOGY, 2023, 50 (05): : 705 - 709